HMGN5 and prostate carcinoma: Besides on-target cisplatin resistance, HMGN5 may also be involved in post-target resistance, as its knockdown in prostate cancer cells elicited apoptosis and G2-M cell cycle arrest, leading to the sensitization of ionizing radiation30.